Pharmsville Statistics

Total Valuation

Pharmsville has a market cap or net worth of KRW 29.79 billion. The enterprise value is -7.79 billion.

Market Cap	29.79B
Enterprise Value	-7.79B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Pharmsville has 7.73 million shares outstanding. The number of shares has decreased by -0.76% in one year.

Current Share Class	7.73M
Shares Outstanding	7.73M
Shares Change (YoY)	-0.76%
Shares Change (QoQ)	+0.40%
Owned by Insiders (%)	62.87%
Owned by Institutions (%)	n/a
Float	2.01M

Valuation Ratios

The trailing PE ratio is 16.01.

PE Ratio	16.01
Forward PE	n/a
PS Ratio	1.95
PB Ratio	0.46
P/TBV Ratio	0.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.19
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	7.35

Financial Position

The company has a current ratio of 16.20, with a Debt / Equity ratio of 0.00.

Current Ratio	16.20
Quick Ratio	15.36
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-25.97

Financial Efficiency

Return on equity (ROE) is 2.89% and return on invested capital (ROIC) is -0.68%.

Return on Equity (ROE)	2.89%
Return on Assets (ROA)	-0.64%
Return on Invested Capital (ROIC)	-0.68%
Return on Capital Employed (ROCE)	-1.09%
Revenue Per Employee	462.74M
Profits Per Employee	56.39M
Employee Count	33
Asset Turnover	0.22
Inventory Turnover	2.55

Taxes

In the past 12 months, Pharmsville has paid 218.29 million in taxes.

Income Tax	218.29M
Effective Tax Rate	10.50%

Stock Price Statistics

The stock price has decreased by -37.58% in the last 52 weeks. The beta is 0.00, so Pharmsville's price volatility has been lower than the market average.

Beta (5Y)	0.00
52-Week Price Change	-37.58%
50-Day Moving Average	3,619.30
200-Day Moving Average	4,234.85
Relative Strength Index (RSI)	58.43
Average Volume (20 Days)	9,592

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmsville had revenue of KRW 15.27 billion and earned 1.86 billion in profits. Earnings per share was 240.77.

Revenue	15.27B
Gross Profit	9.60B
Operating Income	-709.45M
Pretax Income	2.08B
Net Income	1.86B
EBITDA	-33.68M
EBIT	-709.45M
Earnings Per Share (EPS)	240.77

Full Income Statement

Balance Sheet

The company has 37.71 billion in cash and 21.37 million in debt, giving a net cash position of 37.69 billion or 4,876.82 per share.

Cash & Cash Equivalents	37.71B
Total Debt	21.37M
Net Cash	37.69B
Net Cash Per Share	4,876.82
Equity (Book Value)	64.96B
Book Value Per Share	8,391.94
Working Capital	38.27B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.04 billion and capital expenditures -16.66 million, giving a free cash flow of -1.06 billion.

Operating Cash Flow	-1.04B
Capital Expenditures	-16.66M
Free Cash Flow	-1.06B
FCF Per Share	-137.21

Full Cash Flow Statement

Margins

Gross margin is 62.83%, with operating and profit margins of -4.65% and 12.19%.

Gross Margin	62.83%
Operating Margin	-4.65%
Pretax Margin	13.62%
Profit Margin	12.19%
EBITDA Margin	-0.22%
EBIT Margin	-4.65%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.56%.

Dividend Per Share	100.00
Dividend Yield	2.56%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	41.65%
Buyback Yield	0.76%
Shareholder Yield	3.39%
Earnings Yield	6.25%
FCF Yield	-3.56%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharmsville has an Altman Z-Score of 10.05 and a Piotroski F-Score of 3.

Altman Z-Score	10.05
Piotroski F-Score	3